CT Texture Analysis of Cervical Lymph Nodes on Contrast-Enhanced [¹⁸F] FDG-PET/CT Images to Differentiate Nodal Metastases from Reactive Lymphadenopathy in HIV-Positive Patients with Head and Neck Squamous Cell Carcinoma

References

1. 1.↵
   Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet 2008;372:293–99 doi:10.1016/S0140-6736(08)61113-7 pmid:18657708

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Bonnet F,
   3. Burty C,
   4. Lewden C, et al

   . Changes in cancer mortality among HIV-infected patients: the Mortalité 2005 Survey. Clin Infect Dis 2009;48:633–39 doi:10.1086/596766 pmid:19202627

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Coghill AE,
   3. Shiels MS,
   4. Suneja G, et al

   . Elevated cancer-specific mortality among HIV-infected patients in the United States. J Clin Oncol 2015;33:2376–83 doi:10.1200/JCO.2014.59.5967 pmid:26077242

   Abstract/FREE Full Text
4. 4.↵
   2. Mourad WF,
   3. Hu KS,
   4. Shasha D, et al

   . Long-term outcome of seropositive HIV patients with head and neck squamous cell carcinoma treated with radiation therapy and chemotherapy. Anticancer Res 2013;33:5511–16 pmid:24324090

   Abstract/FREE Full Text
5. 5.↵
   2. Powles T,
   3. Robinson D,
   4. Stebbing J, et al

   . Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol 2009;27:884–90 doi:10.1200/JCO.2008.19.6626 pmid:19114688

   Abstract/FREE Full Text
6. 6.↵
   2. Beachler DC,
   3. Sugar EA,
   4. Margolick JB, et al

   . Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults. Am J Epidemiol 2015;181:40–53 doi:10.1093/aje/kwu247 pmid:25480823

   CrossRefPubMedWeb of Science
7. 7.↵
   2. Frisch M,
   3. Biggar RJ,
   4. Engels EA, et al

   . Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285:1736–45 doi:10.1001/jama.285.13.1736 pmid:11277828

   CrossRefPubMedWeb of Science
8. 8.↵
   2. McLemore MS,
   3. Haigentz M Jr.,
   4. Smith RV, et al

   . Head and neck squamous cell carcinomas in HIV-positive patients: a preliminary investigation of viral associations. Head Neck Pathol 2010;4:97–105 doi:10.1007/s12105-010-0171-9 pmid:20333562

   CrossRefPubMed
9. 9.↵
   2. Spano JP,
   3. Costagliola D,
   4. Katlama C, et al

   . AIDS-related malignancies: state of the art and therapeutic challenges. J Clin Oncol 2008;26:4834–42 doi:10.1200/JCO.2008.16.8252 pmid:18591544

   Abstract/FREE Full Text
10. 10.↵
    2. D'Souza G,
    3. Carey TE,
    4. William WN Jr., et al

    . Epidemiology of head and neck squamous cell cancer among HIV-infected patients. J Acquir Immune Defic Syndr 2014;65:603–10 doi:10.1097/QAI.0000000000000083 pmid:24326607

    CrossRefPubMed
11. 11.↵
    2. Olsen WL,
    3. Jeffrey RB Jr.,
    4. Sooy CD, et al

    . Lesions of the head and neck in patients with AIDS: CT and MR findings. AJR Am J Roentgenol 1988;151:785–90 doi:10.2214/ajr.151.4.785 pmid:3262281

    CrossRefPubMed
12. 12.↵
    2. Holliday RA,
    3. Cohen WA,
    4. Schinella RA, et al

    . Benign lymphoepithelial parotid cysts and hyperplastic cervical adenopathy in AIDS-risk patients: a new CT appearance. Radiology 1988;168:439–41 doi:10.1148/radiology.168.2.3393663 pmid:3393663

    CrossRefPubMedWeb of Science
13. 13.↵
    2. Quon A,
    3. Fischbein NJ,
    4. McDougall IR, et al

    . Clinical role of ¹⁸F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. J Nucl Med 2007;48(Suppl 1):58S–67S pmid:17204721

    Abstract/FREE Full Text
14. 14.↵
    2. Kyzas PA,
    3. Evangelou E,
    4. Denaxa-Kyza D, et al

    . 18FF-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 2008;100:712–20 doi:10.1093/jnci/djn125 pmid:18477804

    CrossRefPubMed
15. 15.↵
    2. Gupta T,
    3. Master Z,
    4. Kannan S, et al

    . Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 2011;38:2083–95 doi:10.1007/s00259-011-1893-y pmid:21853309

    CrossRefPubMed
16. 16.↵
    2. Davison JM,
    3. Subramaniam RM,
    4. Surasi DS, et al

    . FDG PET/CT in patients with HIV. AJR Am J Roentgenol 2011;197:284–94 doi:10.2214/AJR.10.6332 pmid:21785073

    CrossRefPubMed
17. 17.↵
    2. Sathekge M,
    3. Maes A,
    4. Kgomo M, et al

    . Fluorodeoxyglucose uptake by lymph nodes of HIV patients is inversely related to CD4 cell count. Nucl Med Commun 2010;31:137–40 doi:10.1097/MNM.0b013e3283331114 pmid:19996812

    CrossRefPubMed
18. 18.↵
    2. Sathekge M,
    3. Maes A,
    4. Van de Wiele C

    . FDG-PET imaging in HIV infection and tuberculosis. Semin Nucl Med 2013;43:349–66 doi:10.1053/j.semnuclmed.2013.04.008 pmid:23905617

    CrossRefPubMed
19. 19.↵
    2. Frankel SS,
    3. Tenner-Racz K,
    4. Racz P, et al

    . Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am J Pathol 1997;151:89–96 pmid:9212735

    PubMedWeb of Science
20. 20.↵
    2. Goldenberg D,
    3. Sciubba J,
    4. Koch WM

    . Cystic metastasis from head and neck squamous cell cancer: a distinct disease variant? Head Neck 2006;28:633–38 doi:10.1002/hed.20381 pmid:16477605

    CrossRefPubMed
21. 21.↵
    2. Bayanati H,
    3. Thornhill RE,
    4. Souza CA, et al

    . Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol 2015;25:480–87 doi:10.1007/s00330-014-3420-6 pmid:25216770

    CrossRefPubMed
22. 22.↵
    2. Huang YQ,
    3. Liang CH,
    4. He L, et al

    . Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol 2016;34:2157–64 doi:10.1200/JCO.2015.65.9128 pmid:27138577

    Abstract/FREE Full Text
23. 23.↵
    2. Knogler T,
    3. El-Rabadi K,
    4. Weber M, et al

    . Three-dimensional texture analysis of contrast enhanced CT images for treatment response assessment in Hodgkin lymphoma: comparison with F-18-FDG PET. Med Phys 2014;41:121904 doi:10.1118/1.4900821 pmid:25471964

    CrossRefPubMed
24. 24.↵
    2. Buch K,
    3. Fujita A,
    4. Li B, et al

    . Using texture analysis to determine human papillomavirus status of oropharyngeal squamous cell carcinomas on CT. AJNR Am J Neuroradiol 2015;36:1343–48 doi:10.3174/ajnr.A4285 pmid:25836725

    Abstract/FREE Full Text
25. 25.↵
    2. Fujita A,
    3. Buch K,
    4. Li B, et al

    . Difference between HPV-positive and HPV-negative non-oropharyngeal head and neck cancer: texture analysis features on CT. J Comput Assist Tomogr 2016;40:43–47 doi:10.1097/RCT.0000000000000320 pmid:26466116

    CrossRefPubMed
26. 26.↵
    2. Haralick RM,
    3. Shanmugam K,
    4. Dinstein IH

    . Textural features for image classification. IEEE Transactions on Systems, Man and Cybernetics 1973:SMC-3:610–21 doi:10.1109/TSMC.1973.4309314 pmid:26477447

    CrossRefPubMed
27. 27.↵
    2. Laws KI

    . Textured Image Segmentation [dissertation and thesis]. Los Angeles: University of Southern California; 1980
28. 28.↵
    2. Tang X

    . Texture information in run-length matrices. IEEE Trans Image Process 1998;7:1602–09 doi:10.1109/83.725367 pmid:18276225

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Castellano G,
    3. Bonilha L,
    4. Li LM, et al

    . Texture analysis of medical images. Clin Radiol 2004;59:1061–69 doi:10.1016/j.crad.2004.07.008 pmid:15556588

    CrossRefPubMed
30. 30.↵
    2. Yu H,
    3. Buch K,
    4. Li B, et al

    . Utility of texture analysis for quantifying hepatic fibrosis on proton density MRI. J Magn Reson Imaging 2015;42:1259–65 doi:10.1002/jmri.24898 pmid:26477447

    CrossRefPubMed
31. 31.↵
    2. Li B,
    3. Jara H,
    4. Yu H, et al

    . Enhanced Laws textures: a potential MRI surrogate marker of hepatic fibrosis in a murine model. Magn Reson Imaging 2017;37:33–40 doi:10.1016/j.mri.2016.11.008 pmid:27856399

    CrossRefPubMed
32. 32.↵
    2. Liu H,
    3. Wu T

    . Estimating the area under a receiver operating characteristic (ROC) curve for repeated measures design. Journal of Statistical Software 2003;8:1–18 doi:10.18637/jss.v008.i12

    CrossRef
33. 33.↵
    2. Pham TD,
    3. Watanabe Y,
    4. Higuchi M, et al

    . Texture analysis and synthesis of malignant and benign mediastinal lymph nodes in patients with lung cancer on computed tomography. Sci Rep 2017;7:43209 doi:10.1038/srep43209 pmid:28233795

    CrossRefPubMed
34. 34.↵
    2. Brust D,
    3. Polis M,
    4. Davey R, et al

    . Fluorodeoxyglucose imaging in healthy subjects with HIV infection: impact of disease stage and therapy on pattern of nodal activation. AIDS 2006;20:985–93 doi:10.1097/01.aids.0000222070.52996.76 pmid:16603850

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Mhlanga JC,
    3. Durand D,
    4. Tsai HL, et al

    . Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry. Eur J Nucl Med Mol Imaging 2014;41:596–604 doi:10.1007/s00259-013-2671-9 pmid:24469258

    CrossRefPubMed
36. 36.↵
    2. Lawal IO,
    3. Nyakale NE,
    4. Harry LM, et al

    . The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 2017;44:2025–33 doi:10.1007/s00259-017-3766-5 pmid:28660348

    CrossRefPubMed